Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report
Wen Dong, Zemin Xiao(The First People's Hospital of Changde), Siyan Li(Jiaxing University), Zhijun Wu(Nanjing Agricultural University), Yangfeng Du(Central South University), Tao Wu(Central South University), Yan Zhang(Liaoning Shihua University), Hongming Wang(China Medical University), Juan Cai(Wannan Medical College), Yan Zhou(Chinese University of Hong Kong, Shenzhen), Jiang Zheng(Chongqing University), Anli Dai(Central South University), Wei Tian(Central South University), Jiangtao Wang(Central South University), Susu Dong(Central South University)
Cited by 7
Related Papers
DNA methylation on N6-adenine in mammalian embryonic stem cells
|Nature|2016|672
Chemisorption of CO and Mechanism of CO Oxidation on Supported Platinum Nanoclusters
|Journal of the American Chemical Society|2011|577
N-methyladenine DNA Modification in Glioblastoma
|Cell|2018|340
Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells
|BMC Molecular Biology|2009|193
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183